Abstract
Emerging treatments for dry age-related macular degeneration (AMD) and geographic atrophy focus on two strategies that target components involved in physiopathological pathways: prevention of photoreceptors and retinal pigment epithelium loss (neuroprotection induction, oxidative damage prevention, and visual cycle modification) and suppression of inflammation. Neuroprotective drugs, such as ciliary neurotrophic factor, brimonidine tartrate, tandospirone, and anti-amyloid β antibodies, aim to prevent apoptosis of retinal cells. Oxidative stress and depletion of essential micronutrients are targeted by the Age-Related Eye Disease Study (AREDS) formulation. Visual cycle modulators reduce the activity of the photoreceptors and retinal accumulation of toxic fluorophores and lipofuscin. Eyes with dry age-related macular degeneration present chronic inflammation and potential treatments include corticosteroid and complement inhibition. We review the current concepts and rationale of dry age-related macular degeneration treatment that will most likely include a combination of drugs targeting different pathways involved in the development and progression of age-related macular degeneration.
Citations
Nov 7, 2019·Frontiers in Aging Neuroscience·Zofia LitwińskaAnna Machalińska
Aug 27, 2013·Expert Review of Clinical Pharmacology·Ella Leung, Gennady Landa
Jan 7, 2015·Ophthalmic Surgery, Lasers & Imaging Retina·Hershel R Patel, David Eichenbaum
Sep 23, 2014·Expert Opinion on Investigational Drugs·Michael John TolentinoMichael Steven Tolentino
Feb 8, 2016·Cellular and Molecular Life Sciences : CMLS·Anu KauppinenKai Kaarniranta
Feb 16, 2016·Ophthalmic Surgery, Lasers & Imaging Retina·Pravin U Dugel, Cheryl N Zimmer
Jun 16, 2015·The Journal of Clinical Investigation·Jianye ZhangKrzysztof Palczewski
Mar 3, 2020·Expert Opinion on Therapeutic Targets·Saeed MehrzadiAzam Hosseinzadeh
Feb 8, 2014·Eye·D T Q BarbosaS C Lin
Mar 25, 2015·Molecular and Cellular Biology·Jakub HanusShusheng Wang
Jan 29, 2014·The AAPS Journal·Shankar SwaminathanMonica M Jablonski
May 10, 2013·Cell Cycle·Oyuna S KozhevnikovaNatalia G Kolosova
Sep 10, 2014·European Journal of Ophthalmology·Antonios PipisAlbert J Augustin
Oct 24, 2015·Eye·M Gemenetzi, A J Lotery
Jun 14, 2018·International Journal of Molecular Sciences·Shuai LiWenhua Zheng
Jan 6, 2017·Cell Death & Disease·Ki-Hong JangEunhee Kim
Feb 7, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rebecca M SchurZheng-Rong Lu
Aug 18, 2017·Expert Opinion on Investigational Drugs·Huiling LiMonica M Jablonski
Jan 6, 2018·Journal of Global Health·Peige SongIgor Rudan
Jun 21, 2020·Ophthalmology Retina·Muneeswar G NittalaSrinivas R Sadda
May 29, 2018·International Journal of Pharmaceutics·Farnaz BehrooziHossein Baharvand
Jul 13, 2021·Translational Vision Science & Technology·Nan ZhangJohn M Nickerson